Moffitt research shows gene may help in treating pancreatic cancer

in Uncategorized by

Moffitt Cancer Center researchers have identified a gene that may better predict survival for pancreatic adenocarcenoma, the fourth leading cause of cancer death in the United States.

Dr. Richard Kim, an assistant member of the Experimental Therapeutics Program and other researchers, studied the role of a gene involved in helping target gemcitabine, a commonly used chemotherapy in pancreatic cancer, according to a statement.

The retrospective study focused on 122 patients. A validation study would be necessary before clinical application of the research findings.

Kim worked with researchers from Cleveland Clinic, Case Western Reserve University School of Medicine, Veridex LLC, and Johnson & Johnson Co. on the study.

Moffitt, located in Tampa, is a National Cancer Institute-designated comprehensive cancer center.

Peter Schorsch is the President of Extensive Enterprises and is the publisher of some of Florida’s most influential new media websites, including,,, and Sunburn, the morning read of what’s hot in Florida politics. SaintPetersBlog has for three years running been ranked by the Washington Post as the best state-based blog in Florida. In addition to his publishing efforts, Peter is a political consultant to several of the state’s largest governmental affairs and public relations firms. Peter lives in St. Petersburg with his wife, Michelle, and their daughter, Ella.